Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)

NCT02797626 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Stage II A/B Seminomatous Germ Cell Tumors

Interventions

PROCEDURE: Primary retroperitoneal lymph-node dissection (pRPLND)

Sponsor

Heinrich-Heine University, Duesseldorf